Although further studies are needed to investigate the anti-inflammatory potential of oxytocin in patients with COVID-19, these studies open the way to further investigating the role of the oxytocinergic system as a valid therapeutic target for the prevention and/or mitigation of the cytokine storm triggered by SARS-CoV-2 infection. Here, OXT is linked to COVID-19.